Targeted liposomal drug delivery: a nanoscience and biophysical perspective
Таргетная доставка лекарственных средств с помощью липосом: нанонаучный и биофизический аспект
2020-12-21
SCID: 54.1/2ssuft8k
Discuss with AI
PEGylated liposomesactive targeting ligandsenhanced permeability and retention effectliposome biophysical propertiestargeted liposomal drug delivery
Figures from the paper
Abstract (AI)
Liposomes are a unique platform for drug delivery, and a number of liposomal formulations have already been commercialized. Doxil is a representative example, which uses PEGylated liposomes to load doxorubicin for cancer therapy. Its delivery relies on the enhanced permeability and retention (EPR) effect or passive targeting. Drug loading can be achieved using both standard liposomes and also those containing a solid core such as mesoporous silica and poly(lactide-co-glycolide) (PLGA). Developments have also been made on active targeted delivery using bioaffinity ligands such as small molecules, antibodies, peptides and aptamers. Compared to other types of nanoparticles, the surface of liposomes is fluid, allowing dynamic organization of targeting ligands to achieve optimal binding to cell surface receptors. This review article summarizes development of liposomal targeted drug delivery systems, with an emphasis on the biophysical properties of lipids. In both passive and active targeting, the effects of liposome size, charge, fluidity, rigidity, head-group chemistry and PEGylation are discussed along with recent examples. Most of the examples are focused on targeting tumors or cancer cells. Finally, a few examples of commercialized formulations are described, and some future research opportunities are discussed.
Key Findings
1
Active targeting uses bioaffinity ligands including small molecules, antibodies, peptides, and aptamers.
2
Drug loading is possible in conventional liposomes and in liposomes incorporating solid cores such as mesoporous silica or PLGA.
3
Liposome size, charge, fluidity, rigidity, head-group chemistry, and PEGylation critically influence passive and active targeting performance.
4
Liposomes provide a clinically validated drug-delivery platform, exemplified by PEGylated doxorubicin-loaded Doxil.
5
Passive tumor targeting in liposomal delivery relies primarily on the enhanced permeability and retention effect.
6
Unlike many nanoparticles, fluid liposome surfaces can dynamically reorganize targeting ligands to optimize binding to cell-surface receptors.
Research Object
liposomal targeted drug delivery systems for tumors and cancer cells
Research Subject
the biophysical lipid properties and targeting mechanisms governing passive and active drug delivery, including the effects of liposome size, charge, fluidity, rigidity, head-group chemistry, PEGylation, and targeting-ligand organization
Publication Details
Publication Date
2020-12-21
Journal
Publisher
ISSN
Cited by
294
Access Type
Author Information
Download PDF
Subscribe to digest